Tripod Therapeutics

Harnessing the Power of Proteasome Dynamics to Treat Cancer

Health Tech & Life Sciences
Active
Pre-Funding Haifa Founded 2022
Total raised
Stage
Pre-Funding
Founded
2022
Headcount
4
HQ
Haifa
Sector
Health Tech & Life Sciences

About

Tripod Therapeutics is a biopharmaceutical company that specializes in proteasome dynamics and its manipulation for treating illnesses. It was established on the basis of comprehensive scientific research conducted by Nobel Prize Laureate Prof Aaron Ciechanover and his team.

Tripod Therapeutics is developing an orally available drug substance that regulates proteasome localization, thus tricking cancer cells and leading them to their death. The company has already demonstrated the efficacy of its novel approach in several animal models of cancer, and are now working towards the initiation of pre-clinical trials and clinical studies.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

drug-developmentcancer-therapyoncologycancerpharmaceuticals